Eyal Attar

Eyal Attar has a extensive work experience in the medical field. Eyal is currently working as the Chief Medical Officer at Vor Biopharma since October 2022. Prior to joining Vor Biopharma, they worked at Aprea Therapeutics as the Chief Medical Officer from March 2019 to October 2022.

Before their tenure at Aprea Therapeutics, Eyal Attar held the position of Senior Medical Director at Agios Pharmaceuticals from 2014 to 2019. Eyal started their career as an Attending Physician at Harvard Medical School - Massachusetts General Hospital in 2003 and worked there till 2014.

Eyal Attar has also worked as a Clinical and Research Fellow at Dana-Farber Cancer Institute Inc from June 1999 to May 2003. Earlier in their career, they worked as a Resident Physician at Brigham and Women's Hospital from July 1997 to June 1999.

Eyal Attar obtained a Bachelor's degree in Chemistry from the University of North Carolina at Chapel Hill in 1992. Subsequently, they pursued further education at the University of North Carolina at Chapel Hill School of Medicine and earned an M.D. degree in 1997.